News & Media

STATEMENT: Michigan State Medical Society Supports FDA Decision to Approve COVID-19 Vaccine for Children 5 and Under

STATEMENT: Michigan State Medical Society Supports FDA Decision to Approve COVID-19 Vaccine for Children 5 and Under

Wednesday, June 22, 2022

The following is a public statement from Thomas Veverka, MD, FACS president of the Michigan State Medical Society in response to the Food and Drug Administration’s (FDA’s) authorization of the use of the Pfizer three-dose vaccine for children ages six months through 4 years old, and the Moderna two-dose vaccine for children six months through 5 years old.


“The Michigan State Medical Society fully supports the FDA’s decision to authorize the use of the Pfizer and Moderna vaccines for children 5 and under. For nearly a year and half now, a lot of families with very young children have been waiting anxiously for this day to come, so it’s a huge relief to finally be able to say almost every American can now receive the critical protection against COVID-19 that these vaccines offer.

 

“The FDA has properly studied the safety and efficacy of these vaccines in this age cohort and the results are clear: the benefits of the vaccine greatly outweigh any risks.  The vaccine is safe, effective, and the best way to keep our youngest children healthy and safe. We encourage parents everywhere to act to get their children vaccinated and protected as soon as possible.”